Clinical Trials Logo
  1. Home
  2. Renin Angiotensin System
  3. NCT01049646

Interaction of Apelin and Angiotensin in the Systemic Circulation

Renin Angiotensin System Clinical Trial

Clinical Trial Summary

The apelin-APJ system is a relatively new discovery. It has generated interest in part due to it's apparent ability to counteract the renin-angiotensin system, which is frequently overactive in many cardiovascular disease.

Apelin improves that pumping ability of the heart and we wish to know if this action persists in the presence of increased levels of angiotensin II.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01049646
Study type Interventional
Source University of Edinburgh
Contact
Status Completed
Phase N/A
Start date January 2010
Completion date April 2010
View Details
See also
  Status Clinical Trial Phase
Completed NCT00674596 - The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria Phase 4
Completed NCT03374449 - Impact of Renin-Angiotensin System Inhibitors Continuation on Outcome After Major Surgery N/A
Recruiting NCT00517322 - Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan Phase 4